These strategies aim to either reduce MYC transcription, translation, or stability; target MYC’s interactions with its binding partners; block MYC’s access to downstream genes; or exploit the vulnerabilities of MYC-dependent tumor cells through efficient synthetic lethality combinations [70,71]. This evidence concerns the gene MYC and neoplasm.